FAS and cancer: Our results revealed that the addition of 30% PAS in medium can inhibit the viability of both T24 and J82 cells through enhancing the intracellular ROS level, and trigger cancer cell apoptosis by activating the ROS-mediated Fas/CD95 pathway.